Army war on COVID-19 saves soldiers’ lives with remdesivir anti-viral drug “So far we have seen success with remdesivir to the point where we have gotten a few service members excavated and actually discharged https://www.foxnews.com/tech/army-war-on-covid-19-saves-soldiers-lives-with-remdesivir-anti-viral-drug
Framus, según he leído, ese fenómeno es propio de momentos de crisis como estas , con desempleo masivo, etc , momentos que algunos broker aprovechan para hacer su agosto captando clientes, ofreciéndoles , formación gratis, bajas comisiones, y fuertes beneficios, desde casa, o desde la 2da residencia o desde un hotel en el Caribe con .una/o ........ al lado ....etc,ja,ja,ja, pues va a ser que si , que muchos caerán.
APRIL 28, 2020INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June http://ir.inovio.com/news-releases/default.aspx
Coronavirus vaccine could be ready in 2020 a vaccine could be available as early as this year for vulnerable groups like healthcare workers, The foundation, which is supporting nine different COVID-19 vaccine projects, has provided funding to Moderna (NASDAQ:MRNA) Novavax (NASDAQ:NVAX) and Inovio Pharmaceuticals (NASDAQ:INO). https://seekingalpha.com/news/3565057-coronavirus-vaccine-be-ready-in-2020
Japan on board with Gilead's remdesivir, approval expected in May https://seekingalpha.com/news/3564630-japan-on-board-gileads-remdesivir-approval-expected-in-may?utm_medium=email&utm_source=seeking_alpha&mail_subject=gild-japan-on-board-with-gilead-s-remdesivir-approval-expected-in-may&utm_campaign=rta-stock-news&utm_content=link-3 Prime Minister Shinzo Abe said Monday that Japan will soon approve the anti-viral drug remdesivir for the treatment of coronavirus patients, in what will be the country's first such decision amid the pandemic. https://english.kyodonews.net/news/2020/04/96de780ad3e1-japan-to-approve-remdesivir-for-coronavirus-patients-in-may.html
DVAX Market Cap | 268.67M Inst Own | 75.10% RSI (14) | 49.63 Dynavax to Report First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020 https://finance.yahoo.com/news/dynavax-report-first-quarter-2020-201010941.html Dynavax and Sinovac Announce Collaboration to Develop a Coronavirus (COVID-19) Vaccine https://finance.yahoo.com/news/dynavax-sinovac-announce-collaboration-develop-113010593.html
MESO +139.5 %83% Survival in COVID-19 Patients with Moderate/Severe Acute Respiratory Distress Syndrome Treated in New York with Mesoblast’s Cell Therapy Remestemcel-L 75% (9/12) have successfully come off ventilator support within a median of 10 days These results contrast with only 9% of ventilator-dependent COVID-19 patients being able to come off ventilators with standard of care treatment https://finance.yahoo.com/news/83-survival-covid-19-patients-100010532.html